Evoke Pharma Inc Sustainability Reports
Evoke Pharma Inc. is a pharmaceutical company that focuses on the development and commercialization of drugs for gastrointestinal disorders and diseases. Its primary product is GIMOTI, a nasal spray indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900Q01Z5E3L6MZZ66
4 reports from 2013 to 2024
Company Profile
Evoke Pharma Inc. is a pharmaceutical company that focuses on the development and commercialization of drugs for gastrointestinal disorders and diseases. Its primary product is GIMOTI, a nasal spray indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
Reports
4 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
